TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186 | -66.4% | 22,300 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $554 | +199.5% | 22,300 | +81.3% | 0.00% | +200.0% |
| Q1 2023 | $185 | -99.8% | 12,300 | -28.5% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +39.7% | 17,200 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -65.4% | 17,200 | -22.5% | 0.00% | -100.0% |
| Q1 2022 | $211,000 | -50.0% | 22,200 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $422,000 | -42.9% | 22,200 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $739,000 | -14.2% | 22,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $861,000 | -15.3% | 22,200 | +5.2% | 0.00% | -33.3% |
| Q1 2021 | $1,017,000 | -7.4% | 21,100 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $1,098,000 | +94.3% | 21,100 | 0.0% | 0.01% | +75.0% |
| Q3 2020 | $565,000 | -31.3% | 21,100 | -50.0% | 0.00% | +33.3% |
| Q2 2020 | $822,000 | – | 42,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |